There were 361 press releases posted in the last 24 hours and 440,604 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Alector Announces Promising Preliminary Data from AL001 Phase 1b and Phase 2 Open-Label Long-Term Dosing Study of People with Frontotemporal Dementia

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image